braun getty wide

MLB official says Ryan Braun’s 50-game PED suspension is unlikely to be overturned

38 Comments

At some point within the next few weeks, Brewers outfielder Ryan Braun will have the opportunity to plead his innocence against a charge that he was taking performance-enhancing drugs around the start of the 2011 postseason. But he faces great odds.

The evidence against him comes in the form of a test, administered in either late September or early October, that had a positive reading for elevated levels of testosterone. That test was then passed along to the World Anti-Doping Agency lab in Montreal, where it was determined through further examination that the testosterone was synthetic — not produced by Braun’s body.

Braun might argue that the result was a false-positive, but an expert in the field of drug testing told Jeff Passan of Yahoo! Sports last month that those are “almost impossible” with today’s technology. Braun might say that result was triggered by a prescribed medication — something non-performance-enhancing — but how can he prove that and would it really matter if he could? The test showed insanely high levels of unnatural testosterone. However that testosterone arrived in Braun’s system, it’s against the rules for it to be there.

And even if Braun is telling the truth, and has never put synthetic testosterone into his body, a test that boasts an accuracy rating of nearly 100 percent says that the stuff was, at one point, present.

Which leads us to a report from Tom Haudricourt of the Milwaukee Journal Sentinel, who was told this weekend by an “MLB official familiar with the process” that Braun’s 50-game suspension is unlikely to be overturned. The 2011 NL MVP deserves his day in court, and he’ll get it later this month when he presents his case in front of an arbitrator, but it’s nearly certain that he’ll miss close to one-third of the 2012 campaign.

Jose Bautista and the Blue Jays nearing a two-year, $35-40 million deal

Toronto Blue Jays Jose Bautista flips his bat after hitting a three-run homer during seventh inning game 5 American League Division Series baseball action in Toronto on Wednesday, Oct. 14, 2015. (Nathan Denette/The Canadian Press via AP) MANDATORY CREDIT
Getty Images
4 Comments

It was first reported that the Blue Jays and Jose Bautista were close to a deal last night. Now Ken Rosenthal reports that the deal is near completion. It will likely a two-year contract in the $35-40 million range.

Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.

The Jays, who already lost Edwin Encarnacion to free agency, get their slugger back on a short term deal. Unlike anyone else, they don’t have to give up the draft pick attached to him via the qualifying offer. Bautista, in turn, will make, on average, more than he would’ve made on the qualifying offer if he would’ve accepted it and a raise over the $14 million he made in 2016.

Padres sign Trevor Cahill

Chicago Cubs relief pitcher Trevor Cahill (53) during the seventh inning of Game 3 in baseball's National League Division Series against the St. Louis Cardinals, Monday, Oct. 12, 2015, in Chicago. (AP Photo/Paul Beaty)
Getty Images
Leave a comment

The Padres have signed Trevor Cahill to a one-year, $1.75 million contract.

As recently as the middle of the 2015 season it looked like Cahill’s career would meet a premature end, but after being released by the Braves and signing with the Cubs in August of that season he has been a remarkably effective reliever. He has posted a 2.61 ERA in 61 games in Chicago and has posted a strikeout rate far above his career norms.

He’s not someone you necessarily want taking the hill when the leverage is high, but in San Diego the leverage won’t be all that high all that often.